Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Self-administered versus clinician-performed BinaxNOW COVID rapid test: a comparison of accuracy.
Journal: Microbiology spectrum
Published: February 13, 2024
Feasibility of and Experience With Free State-Funded Telehealth-Based Patient Self-referral for COVID-19 Monoclonal Antibody Therapy.
Journal: Disaster medicine and public health preparedness
Published: September 13, 2023
Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants.
Journal: Clinical pharmacology in drug development
Published: July 12, 2023
Accuracy of Expired BinaxNOW Rapid Antigen Tests.
Journal: Microbiology spectrum
Published: July 10, 2023
Health care policy that relies on poor measurement is ineffective: Lessons from the hospital readmissions reduction program.
Journal: Health services research
Published: April 18, 2023
Improving healthcare value: Medicare reimbursement for short-stay inpatient versus outpatient medical hospitalizations.
Journal: Journal of hospital medicine
Published: October 04, 2021
Potential Financial Effects on Hospitals of the Removal of Common Orthopaedic and Spinal Procedures From Medicare's "Inpatient-Only" List: A Comparison of the Medicare Fee-for-service Payment Model Versus Maryland's Global Budget Revenue Model.
Journal: The Journal of the American Academy of Orthopaedic Surgeons
Published: June 23, 2021
The increasing impact of length of stay "outliers" on length of stay at an urban academic hospital.
Journal: BMC health services research
Published: March 09, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates.
Journal: Neurobiology of disease
Published: January 25, 2021
Policy in Clinical Practice: Medicare Advantage and Observation Hospitalizations.
Journal: Journal of hospital medicine
Published: November 19, 2019
Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies.
Journal: Clinical pharmacology in drug development
Published: January 18, 2018
Last Updated: 09/26/2026